Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
22 Setembro 2023 - 5:53PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a)
of
the Securities Exchange Act of 1934
(Amendment
No. )
Filed
by the Registrant |
☒ |
|
|
Filed
by a Party other than the Registrant |
☐ |
Check
the appropriate box:
☐ |
Preliminary
Proxy Statement |
|
|
☐ |
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
☐ |
Definitive
Proxy Statement |
|
|
☒ |
Definitive
Additional Materials |
|
|
☐ |
Soliciting
Material Pursuant to § 240.14a-12 |
INTERPACE
BIOSCIENCES, INC.
(Name
of Registrant as Specified in Its Charter)
Not
applicable
(Name
of Person(s) Filing Proxy Statement, if other than the registrant)
Payment
of Filing Fee (Check all boxes that apply):
☒ |
No
fee required. |
|
|
☐ |
Fee
paid previously with preliminary materials. |
|
|
☐ |
Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Interpace Biosciences (QX) (USOTC:IDXG)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Interpace Biosciences (QX) (USOTC:IDXG)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Interpace Biosciences Inc (QX) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Interpace Biosciences Inc (QX)